Cardiovascular risk factors in Norwegian women using oral contraceptives: Results from a cardiovascular health screening 1985-88

Contraception

Volumn 53, Issue 6, 1996, Pages 337-344

  Graff Iversen, Sidsel ^a   Tverdal, Aage ^a   Stensvold, Inger ^a  

^a National Health Screening Service   (Norway)

Author keywords

blood pressure; oral contraceptives; serum lipids; smoking

Indexed keywords

DESOGESTREL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LYNESTRENOL; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; CORONARY RISK; DOSE RESPONSE; DRUG FORMULATION; DRUG MIXTURE; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; NORWAY; ORAL CONTRACEPTION; SCREENING; SMOKING;

EID: 0030010938     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(96)00082-0     Document Type: Article

References (28)

1. Royal College of General Practitioners' Oral Contraceptive Study. Mortality among oral contraceptive users. Lancet 1977;2:727-31.
2. Vessey MP, Villard-Mackintosh L, McPherson K, Yeates D. Mortality among oral contraceptive users: 20-year follow-up of women in a cohort study. Br Med J 1989;299:1487-91.
3. Lidegaard Ø. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study. Br Med J 1993;306:956-63.
4. Rosenberg L, Palmer JR, Lesko SM, Shapiro S. Oral contraceptive use and the risk of myocardial infarction. Am J Epidemiol 1990;131:1009-16.
5. Royal College of General Practitioner's Oral Contraceptive Study. Further analyses of mortality in oral contraceptive users. Lancet 1981;1:541-6.
6. Cairns V, Keil U, Doering A, Koenig W, Stieber J, Kleinbaum DG. Oral contraceptive use and blood pressure in a German metropolitan population. Int J Epidemiol 1985;14:389-95.
7. Godsland IF, Crook D, Simpson R et al. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. N Engl J Med 1990; 323:1375-81.
8. Sirtori CR, Calabresi L, Franceschini G et al. Comparison of the lipoprotein and hemostatic changes after a triphasic and a monophasic low-dose oral contraceptive in premenopausal middle-aged women. Atherosclerosis 1990;84:203-11.
9. World Health Organization Task Force on Oral Contraceptives. A multicentre comparative study of serum lipids and lipoproteins in four groups of combined contraceptive users and a control group of IUD users. Contraception 1988;38:605-29.
10. Beresteijn EC, Korevaar JC, Huijbregts PC, Schouten EG, Burema J, Kok FJ. Perimenopausal increase in serum cholesterol: A 10-year longitudinal study. Am J Epidemiol 1993;137:383-92.
11. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand 1985;Suppl 634:1-70.
12. Röschlau P, Bernt E, Gruber W. Enzymatische Bestimmung des Gesamt-cholesterin in Serum. Z Klin Chem Biochem 1974;12:403-7.
13. Eggstein M, Kreutz FH. Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. Klin Wochenschr 1966;44:262-7.
14. Burstein M, Scholinik HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum precipitation by polyanions. J Lipid Res 1970;11:583-5.
15. Norusis MJ/SPSS Inc. Advanced statistics SPSS /PC+ for the IBM PC/XT/AT. Chicago:SPSS Inc, 1986.
16. Jacobs DR, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol 1990;131:32-47.
17. Lidegaard Ø, Overgaard K, Hauch O. The oral contraceptive user. Acta Obstet Gynecol Scand 1988;67:27-31.
18. Jeune B, Wielandt H. Prevalence of smoking and oral contraception in a sample of Danish young women. Scand J Soc Med 1991;19:44-6.
19. Stadel BV. Oral contraceptives and cardiovascular disease. N Engl J Med 1981;305:672-7.
20. Bass CM, Newschaffer CJ, Klag MJ, Bush TL. Plasma lipoprotein levels as predictors of cardiovascular death in women. Arch Intern Med 1993;153:2209-16.
21. Stensvold I, Tverdal A, Urdal P, Graff-Iversen S. Non-fasting serum triglycerides concentration and mortality from coronary heart disease and any cause in middleaged Norwegian women. Br Med J 1993;307:1318-22.
22. Seed M, Crook D. Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins. Curr Opin Lipidol 1994;5:48-58.
23. Castelli WP. Epidemiology of triglycerides: A view from Framingham. Am J Cardiol 1992;70:3H-9H.
24. Castelli WP. Cardiovascular disease in women. Am J Obstet Gynecol 1988;158:1553-60.
25. Basu J, Mikail MS, Palan PR, Thysen B, Bloch E, Romney SL. Endogenous estradiol and progesterone concentrations in smokers on oral contraceptives. Gynecol Obstet Invest 1992;33:224-7.
26. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The primary prevention of coronary heart disease in women. N Engl J Med 1995;332:1758-66.
27. Stampfer MJ, Willett WC, Colditz GA, Speizer FE, Henneckens CH. A prospective study of past use of oral contraceptive agents and risk of cardiovascular disease. N Engl J Med 1988;319:1313-7.
28. Gaziano JM, Buring JE, Breslow JL et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-34.